Novo Nordisk A/S
- Home
- Companies
- Novo Nordisk A/S
- Products
- Tresiba - Insulin Degludec
Tresiba - Insulin Degludec
FromNovo Nordisk A/S
This is a summary of the European public assessment report (EPAR) for Tresiba. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Tresiba.
Most popular related searches
